Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice (Q41283943)

29 September 2017

title

Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice (English)

1 reference

29 September 2017

0 references

1 reference

1 reference

You-Jin Choi

1

1 reference

29 September 2017

Chae-Hyeon Lee

2

1 reference

29 September 2017

Kang-Yo Lee

3

1 reference

29 September 2017

Seung-Hwan Jung

4

1 reference

29 September 2017

Byung-Hoon Lee

5

1 reference

29 September 2017

publication date

4 March 2015

1 reference

29 September 2017

published in

Toxicological Sciences

1 reference

29 September 2017

volume

145

1 reference

29 September 2017

issue

2

1 reference

29 September 2017

page(s)

273-282

1 reference

Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Long-term use of tetracycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

The origins and uses of mouse outbred stocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Drug-induced liver steatosis and phospholipidosis: cell-based assays for early screening of drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Antibacterial-induced hepatotoxicity. Incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Licochalcone Suppresses LXRα-Induced Hepatic Lipogenic Gene Expression through AMPK/Sirt1 Pathway Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Fatty liver and hepatic function for residents with markedly high serum PCDD/Fs levels in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Urokinase-type plasminogen activator (uPA) stimulates triglyceride synthesis in Huh7 hepatoma cells via p38-dependent upregulation of DGAT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/enhancer-binding protein beta (C/EBPbeta) and C/EBPalpha during adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Transcriptional regulation of fatty acid translocase/CD36 expression by CCAAT/enhancer-binding protein alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Lipopenia and skin barrier abnormalities in DGAT2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Hepatic side-effects of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Hepatic gene expression profiling and lipid homeostasis in mice exposed to steatogenic drug, tetracycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

Protective effect of bicyclol on tetracycline-induced fatty liver in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV049

21 January 2018

Identifiers

DOI

10.1093/TOXSCI/KFV049

1 reference

29 September 2017

1 reference